Clinical Trials
35
Active:34
Completed:0
Trial Phases
1 Phases
Phase 1:12
Drug Approvals
4
NMPA:3
FDA:1
Drug Approvals
Oxycodone Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸羟考酮缓释片
- Approval Number
- 国药准字HJ20210052
- Approval Date
- Jun 30, 2021
NMPA
Oxycodone Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸羟考酮缓释片
- Approval Number
- 国药准字HJ20210051
- Approval Date
- Jun 30, 2021
NMPA
Oxycodone Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸羟考酮缓释片
- Approval Number
- 国药准字HJ20210053
- Approval Date
- Jun 30, 2021
NMPA
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
12 (100.0%)No trials found
News
FDA Approves Zurnai Auto-Injector for Opioid Overdose Emergency Treatment
The FDA has approved Zurnai (nalmefene hydrochloride) auto-injector for emergency treatment of known or suspected opioid overdose in adults and pediatric patients aged 12 years and older.